• Novel Combination Active in Refractory GIST

    7 days ago - By MedPageToday

    Combination treatment with the investigational, selective KIT inhibitor PLX9486 plus sunitinib was safe and active in patients with relapsed or refractory gastrointestinal stromal tumors , a small phase I/II study...
    Read more ...